Pharmacy AI Governance & Readiness
Purpose, ownership, PHI boundaries, pharmacist oversight, evidence, Toll Gates, monitoring, and escalation before AI-supported work approaches medication workflows.
Healthcare AI Governance & Readiness
Govern healthcare AI before it reaches patients, PHI, or clinical workflows.
Scaled Agents helps healthcare teams define AI worker purpose, ownership, PHI and data boundaries, professional review, evidence, monitoring, and escalation paths before AI-supported work moves closer to practice.
PHI and data boundaries
Professional review path
Evidence before reliance
Core Positioning
Govern the AI worker before the workflow depends on it.
Scaled Agents helps healthcare organizations govern AI workers and AI-supported workflows before they touch protected health information, patient communication, medication workflows, clinical decision support, operational systems, or regulated decisions.
AI Governance
Human-in-the-Loop Operations
Agent Passport
Toll Gates
Public Library
Request a Readiness Conversation
Advisor
Passport firstIdentity, owner, scope, data boundary, review status, lifecycle, and evidence context stay connected.
Toll Gate before movementHigher-risk use routes to evidence, human review, escalation, denial, or pause before reliance.
Professional accountabilityAI can draft and organize. Qualified human roles remain accountable for review and use decisions.
Monitoring and stop pathDrift, vendor change, unsafe output, and unclear scope need renewal, redesign, pause, or retirement triggers.
Healthcare Hub
Begin with healthcare AI governance that is specific enough to review.
Pharmacy is the first focused healthcare section because it shows the kind of ownership, PHI boundary, professional review, evidence, monitoring, and escalation questions healthcare teams should resolve before expanding AI-supported work.
Clinical Workflow Governance
Planning language for AI-supported clinical workflow drafts, review boundaries, reliance limits, and escalation paths.
Patient Communication Governance
Review preparation for patient-facing drafts, plain-language review, source verification, and professional approval boundaries.
Revenue Cycle & Administrative AI
Governance preparation for administrative workflows, prior authorization support, queue triage, and evidence organization.
Research & Documentation Support
Controlled use for literature summaries, documentation drafts, source review, and internal knowledge support.
Vendor & Model Review Readiness
Model card, vendor evidence, material-change, privacy/security, and monitoring questions for customer review.
Why Pharmacy AI Needs Governance
AI can support pharmacy work, but the risk boundary moves quickly.
AI can support pharmacy operations, documentation, inventory forecasting, research, patient counseling drafts, drug interaction review support, and clinical decision support summaries. Pharmacy use cases carry elevated risk because outputs may affect patients, medication decisions, PHI, regulated workflows, or trust.
Patient proximity
Drafts, summaries, and recommendations can move toward patient communication or medication workflow decisions unless the operating boundary is explicit.
Data sensitivity
PHI, medication records, payer context, and care-team notes require approved privacy, security, retention, and external-processing boundaries before use.
Professional reliance
AI output should remain draft-only or review-support unless a pharmacist-reviewed operating model, evidence path, and escalation route are defined.
Start With Internal AI Use
Safer starting points keep AI useful while review matures.
Early pharmacy AI work should favor internal, operational, non-patient-facing support where pharmacists and accountable owners can review output before reliance.
SOP drafting
Documentation support for internal procedures, reviewer notes, and controlled update drafts.
Policy Q&A
Internal pharmacy policy Q&A over approved documents with source verification and owner review.
Inventory forecasting
Inventory and demand forecasting support that routes exceptions to responsible staff before action.
Workflow triage
Queue review, routing suggestions, and handoff drafts that remain pharmacist-reviewable.
Training drafts
Training content drafts for review, correction, and approved publication by accountable teams.
Vendor research
Vendor, formulary, or market research summaries with source links and assumptions clearly separated.
Audit preparation
Evidence collection, gap lists, and review packet preparation without final audit or compliance conclusions.
Controlled use planning
Use case intake, owner mapping, data boundary review, Toll Gate planning, and escalation design.
Pharmacy AI Risk Ladder
Classify use before expanding authority.
The risk ladder helps teams separate low-risk internal support from higher-risk activity that needs stronger pharmacist oversight, evidence, privacy/security review, and launch or pause decisions.
Low-risk starting points
Internal, operational, non-patient-facing, and pharmacist-reviewable work.
InternalDraft-onlyReviewable
Moderate-risk uses
Medication therapy management draft notes, drug interaction review support, patient counseling draft scripts, prior authorization support, clinical decision support summaries, and pharmacist-reviewed recommendations.
Pharmacist reviewEvidence neededEscalation path
High-risk or restricted uses
Autonomous dosing recommendations, patient-facing medical advice without pharmacist review, AI changing medication therapy, AI operating directly inside EHR or pharmacy systems without controls, diagnostic or treatment logic that may require medical-device-style review, and any PHI workflow using external APIs without approved privacy/security boundaries.
RestrictedFail closedReview required
Pharmacy Agent Passport
Each pharmacy AI worker should have a governed record.
A Pharmacy Agent Passport is a sample-style readiness record for ownership, intended use, prohibited use, PHI boundaries, model/vendor context, pharmacist review, monitoring, and retirement triggers. It is a governance support artifact, not an approval for clinical or production use.
Pharmacy Agent Passport preview
Example field set for a reviewable planning record. It does not authorize clinical or production use.
OwnershipBusiness and pharmacist review roles are named before use expands.
BoundaryPHI, patient-facing status, tools, external processing, and prohibited use are explicit.
EvidenceModel, vendor, source, limitation, and review records stay attached.
LifecycleMonitoring cadence, escalation, renewal, and retirement triggers remain visible.
AI worker nameHuman-readable name for the AI-supported workflow.
Pharmacy settingCommunity, health-system, specialty, mail order, research, or internal operations.
Business ownerRole accountable for business purpose and operating fit.
Pharmacist owner or pharmacist-in-charge reviewerRole accountable for professional review expectations.
Intended useSpecific draft, summary, routing, research, or support purpose.
Prohibited usesActions, advice, or workflow steps the AI worker must not perform.
Patient-facing statusStaff-only support, draft for pharmacist review, or patient-facing only after approval.
PHI access levelNone, de-identified, minimum necessary, or restricted pending review.
Data sourcesApproved documents, internal records, knowledge bases, or customer-authorized sources.
External API or cloud processingWhether external processing is involved and what review is required.
Model or vendor usedCustomer-selected model, vendor, runtime, or orchestration path.
Model card availabilityWhether model evidence, limitations, or vendor documentation is available.
Clinical decision support flagWhether output may be interpreted as clinical decision support.
Autonomous action flagWhether the AI worker can act without human review; restricted by default.
Human review requirementWho reviews, when review occurs, and what remains draft-only.
Regulatory review flagsSignals for customer legal, privacy, security, clinical, or regulatory review routing.
Failure modesKnown ways the AI worker can be incomplete, outdated, incorrect, or over-relied on.
Hallucination controlsSource verification, confidence notes, citations, and stop conditions.
Bias and equity concernsPopulation, language, access, and data-representation risks to review.
Performance metricsAccuracy, completeness, reviewer correction rate, and workflow quality signals.
Drift monitoring cadenceReview cadence for model, vendor, data, workflow, and output changes.
Escalation pathHow staff pause, report, route, or escalate unsafe or unclear output.
Renewal dateWhen ownership, scope, evidence, and controls should be refreshed.
Retirement triggerConditions that require pause, redesign, replacement, or retirement.
Pharmacy Toll Gates
Named checkpoints before higher-risk movement.
Pharmacy Toll Gates define what must be reviewed, evidenced, approved, blocked, or escalated before an AI worker moves closer to PHI, patients, clinical workflows, external systems, or consequential action.
01IntakeCapture the use case, owner, audience, workflow, and intended support role.
02ClassifyCheck data sensitivity, patient proximity, autonomy, and clinical reliance.
03ReviewRoute professional, privacy, security, data, vendor, and owner questions.
04DecideAllow a bounded path, require evidence, escalate, deny, or pause.
05MonitorTrack correction signals, drift, incidents, renewal needs, and stop conditions.
- Use Case GateConfirms the pharmacy purpose, audience, workflow boundary, owner, and allowed draft or support role.
- PHI/Data GateReviews data classes, minimum-necessary use, external processing, retention, and privacy/security boundaries.
- Clinical Reliance GateChecks whether output could influence medication decisions or clinical judgment and routes for stronger review.
- Pharmacist Review GateDefines the pharmacist oversight point before reliance, patient communication, workflow change, or recommendation use.
- Vendor/Model Evidence GateOrganizes model, vendor, limitation, model-card, data-use, and material-change evidence for customer review.
- Drift & Monitoring GateSets cadence, metrics, correction signals, and triggers for re-review, pause, or redesign.
- Patient Communication GateRequires review of patient-facing drafts, source verification, language clarity, escalation, and pharmacist accountability.
Training Package
Pharmacy AI Governance Foundations.
A readiness training package should prepare pharmacy teams to recognize AI limits, keep PHI boundaries visible, document AI-supported work, and escalate unclear or unsafe output before reliance.
- AI limits, hallucinations, and source verificationHow to identify unsupported or stale output before use.
- PHI and data boundary basicsHow to keep minimum-necessary use, external processing, and retention visible.
- Pharmacist review before relianceWhere professional review is required before action, communication, or recommendation use.
- Safe prompting for pharmacy workflowsHow to request draft-only support without asking AI to make clinical decisions.
- Recognizing unsafe or biased outputsHow to flag equity, language, data-quality, and over-reliance risks.
- Documenting AI-supported workHow to preserve assumptions, sources, reviewer decisions, and evidence references.
- Escalation and incident reportingHow to pause, route, and report unclear, unsafe, or out-of-scope behavior.
- Monitoring model drift and vendor changesHow to re-review when models, data, vendors, workflows, or policies change.
Readiness Review Offer
Pharmacy AI Readiness Review.
The review helps pharmacy teams decide whether an AI-supported workflow should launch, pause, or be redesigned before it reaches patients, PHI, clinical workflows, or regulated decisions.
Review includes
- AI use case inventoryDocument current and proposed pharmacy AI uses.
- Pharmacy risk classificationClassify low, moderate, high, or restricted use.
- PHI/data boundary reviewMap data classes, sources, and external processing questions.
- Pharmacist oversight mappingDefine required professional review and escalation points.
- Agent Passport draftPrepare a draft record for owner review.
- Toll Gate recommendationsIdentify review checkpoints before expanded use.
- Training needs summarySummarize role-based readiness gaps.
- Launch / pause / redesign recommendationProvide a planning recommendation for owner review.
Careful boundary
This readiness review is a planning and governance-support service. It does not provide legal advice, regulatory approval, clinical validation, HIPAA certification, FDA clearance, SaMD determination, audit signoff, or authorization for production clinical use. Customer verification and professional review are required before reliance or use.
Source-Informed Note
Grounded in pharmacy-specific AI implementation concerns.
This pharmacy governance direction is informed by the International Pharmaceutical Federation’s 2025 “Artificial intelligence toolkit for pharmacy”, which emphasizes safe AI use, pharmacist judgment, privacy, bias mitigation, model monitoring, transparency, and responsible implementation.